| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 101 |
| 1 | PREDNISONE | 81 |
| 2 | RITUXIMAB | 69 |
| 3 | METOCLOPRAMIDE HYDROCHLORIDE | 42 |
| 4 | METOCLOPRAMIDE | 38 |
| 5 | CYCLOPHOSPHAMIDE | 35 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 35 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 35 |
| 8 | RISPERIDONE | 14 |
| 9 | ASPIRIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | KETOCONAZOLE 1% | 1 | 0.0082 |
| 1 | OMEPRAZOLE 20MG | 4 | 0.0035 |
| 2 | CYSTEAMINE BITARTRATE | 2 | 0.0019 |
| 3 | ANTI-INHIBITOR COAGULANT COMPLEX | 2 | 0.0018 |
| 4 | ANTIHEMOPHILIC FACTOR HUMAN | 2 | 0.0015 |
| 5 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 2 | 0.0009 |
| 6 | DISULFIRAM | 1 | 0.0009 |
| 7 | CLOZAPINE | 101 | 0.0008 |
| 8 | NATEGLINIDE | 1 | 0.0007 |
| 9 | PSYLLIUM HUSK | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 118 |
| 1 | Corticosteroid [EPC] | 90 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 69 |
| 3 | Alkylating Drug [EPC] | 36 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 5 | Benzodiazepine [EPC] | 13 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 7 | Proton Pump Inhibitor [EPC] | 10 |
| 8 | Expectorant [EPC] | 9 |
| 9 | Opioid Agonist [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Monobactam Antibacterial [EPC] | 5 | 0.0018 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 3 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 4 | Atypical Antipsychotic [EPC] | 118 | 0.0003 |
| 5 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 69 | 0.0002 |
| 7 | Cholinesterase Inhibitor [EPC] | 4 | 0.0002 |
| 8 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 9 | Nonergot Dopamine Agonist [EPC] | 3 | 0.0002 |